Project Grant HT94252410278
Award Date
4/1/24
Completion Date
3/31/27
Dollars Obligated
$451K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This three-year Project Grant from the Defense Health Agency, totaling $847,194, will support research on "BIOMARKERS OF HYPERACUSIS IN AUTISM SPECTRUM DISORDER" at the University of Texas at Dallas from September 2023 through September 2026. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health...
This federal Project Grant award in the amount of $617,537 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 1, 2024 to August 31, 2027, supports research conducted by The University of Texas Southwestern Medical Center (UT Southwestern) to examine heterogeneity in response to disease-modifying therapy for multiple sclerosis. As a prominent academic medical center, UT...
The U.S. Defense Health Agency awarded Sunnybrook Research Institute, a Canadian non-profit research organization, a $302,500 Project Grant (CFDA 12.420 - Military Medical Research and Development) to conduct research focused on "Dissecting Biological Mechanisms Underlying Behavioral Heterogeneity in Autism." The 3-year project, running from Apr 1, 2024 to Mar 31, 2027, aims to investigate the biological underpinnings of the varied behaviors observed in individuals with autism spectrum...
The University of California, San Diego will research the mechanisms of heterogeneous neural expression of autism spectrum disorder under a three-year, $868,542 Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Assistance Listing Number 12.420. This program supports biomedical research that transforms military and public health care through innovative solutions for battlefield...
This $1,408,286 federal Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development (CFDA 12.420) program will fund a crossover randomized controlled trial (RCT) at the University of Texas at Dallas (UTD) to evaluate the effectiveness of an individualized progressive treatment for expanding sound tolerance in adults with autism spectrum disorder. The study aims to advance understanding and treatment of auditory hypersensitivity, a common...
The University of Texas Southwestern Medical Center was awarded a $2,641,871 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to comprehensively upregulate and stabilize frataxin mRNA using antisense oligonucleotides. The goal of this research is to transform health care for service members and the public by investigating medical solutions for the...
The federal Project Grant award of $321,981 was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The funding supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. Specifically, this grant will enable the University of California, Davis to conduct research on "Sensory Processing Contributions to Emotion Dysregulation and...
This federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) provides $361,931 to the University of California, San Diego (UCSD) to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder, with the goal of discovering new targeted therapies. The award period runs from September 30, 2024 to September 29, 2027. UCSD, a leading academic research institution, will leverage its expertise in...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,547,864.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on genetically dissecting the neural circuits underlying anorexia nervosa. The research aims to advance scientific understanding and develop new treatment approaches for this condition, which disproportionately impacts military service members...
This Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $681,989.00 to San Diego State University Foundation to conduct research on mapping white matter connectivity of the developing superior temporal sulcus in autism. The 3-year project, running from Jul 1, 2024 to Jun 30, 2027, aims to advance the scientific understanding of neural development and function in autism spectrum disorder. As a non-profit organization...